Wyeth

...SPPI launched Fusilev in the US. Under the colorectal cancer indication, Fusilev sales are approximately $200 million annually in Europe and Japan where the drug is marketed by Wyeth (WYE) and Takeda. Q1 2009, Fusilev sales totaled $9.4...

In this article: Zevalin, NHL, Cancer, Allergan, FDA, CPB, and Revenue

...and preclinical product candidates. In September 2008, the Company entered into a development and commercialization agreement with Wyeth for cethromycin in the Asia Pacific region excluding Japan. Cethromycin has also completed phase III...

In this article: Cethromycin, Antibiotic, Respiratory disease, Plague, Twitter, and Johnson & Johnson

...protein, tumor necrosis factor (TNF), some panelists said. Those drugs include Abbott Laboratories Inc's (ABT.N) Humira and Enbrel, sold by Amgen Inc (AMGN.O) and Wyeth Known generically as tocilizumab, Actemra is sold in Japan by...

In this article: Tocilizumab, Rheumatoid arthritis, FDA, United States, Cholesterol, Genentech, Arthritis, and Cancer

...colorectal cancer for over a decade in Europe and Japan. Outside the US, Fusilev is marketed by Wyeth (NYSE: WYE) and Takeda and brings in approximately $200 million in annual revenue. Colorectal Cancer: A generic version of leucovorin is...

In this article: Cancer, Zevalin, Revenue, Surgery, Bladder cancer, FDA, and US

...receipt of necessary reimbursement authorizations. Wyeth is also pursuing regulatory approval of bazedoxifene for the prevention and treatment of postmenopausal osteoporosis in Japan In 2000, there were an estimated 3.79 million...

In this article: Osteoporosis, European Medicines Agency, Securities and Exchange Commission, and NYSE

...one in powder form, the other as a pre-mixed liquid. Wyeth is the sole marketer of Enbrel outside of North America excluding Japan where Takeda Pharmaceuticals markets the drug. Etanercept is an example of a protein-based drug created...

In this article: Etanercept, FDA, Tumor necrosis factor-alpha, Adalimumab, TNF Receptor, Alzheimer's disease, Infliximab, Crohn's disease, and Wegener's granulomatosis

...value and the economic downturn. U.S. stocks rose early in the session on Monday amid enthusiasm over Pfizer's move to buy Wyeth and after McDonald's reported earnings that topped expectations. With most Asian markets closed Monday...

In this article: ING, Barclays, Philips Electronics, Crucell, Europe, Fiscal year, Recession, and Bankruptcy

This year Pfizer has bought Wyeth, Merck has acquired Schering-Plough and Roche has bought the shares in Genentech that it did not already own, as the world's biggest pharmaceuticals companies strive to prop up profits. Duac, the...

In this article: GlaxoSmithKline, Merck, Britain, Psoriasis, Eczema, Andrew Witty, Blackstone, and Schering-Plough

...disease. It competes with other popular medicines such as Nexium and Prilosec from AstraZeneca (Charts), Wyeth's (Charts, Fortune 500) Protonix and Prevacid from TAP Pharmaceuticals, a joint venture of Abbott Laboratories Inc. (Charts,...

In this article: Rabeprazole, Dr. Reddy, Defendant, NEW YORK, U.S., Plaintiff, Joint venture, and Protonix